2025 |
Lifecore Biomedical Inc
|
Independent Director |
- |
- |
2024 |
FibroGen Inc
|
Independent Director |
- |
- |
2024 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class B
|
Independent Director |
- |
- |
2024 |
Lifecore Biomedical Inc
|
Independent Director |
- |
- |
2023 |
FibroGen Inc
|
Independent Director |
385.5 K |
81.5 % |
2023 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class B
|
Independent Director |
190 K |
26.7 % |
2023 |
Lifecore Biomedical Inc
|
Independent Director |
- |
- |
2022 |
FibroGen Inc
|
Independent Director |
212.5 K |
-17.4 % |
2022 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class B
|
Independent Director |
150 K |
- |
2022 |
Clearside Biomedical Inc
|
Independent Director |
- |
- |
2022 |
Lifecore Biomedical Inc
|
Independent Director |
- |
- |
2021 |
FibroGen Inc
|
Independent Director |
257.1 K |
-30.9 % |
2021 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
|
Independent Director |
145 K |
0.0 % |
2021 |
Clearside Biomedical Inc
|
Independent Director |
115.8 K |
20.9 % |
2021 |
Lifecore Biomedical Inc
|
Independent Director |
99.8 K |
- |
2020 |
FibroGen Inc
|
Independent Director |
372.1 K |
-14.5 % |
2020 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
|
Independent Director |
145 K |
3.6 % |
2020 |
Clearside Biomedical Inc
|
Independent Director |
95.8 K |
36.8 % |
2020 |
Lifecore Biomedical Inc
|
Director |
- |
- |
2019 |
FibroGen Inc
|
Independent Director |
435.3 K |
64.0 % |
2019 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
|
Independent Director |
140 K |
0.0 % |
2019 |
Clearside Biomedical Inc
|
Independent Director |
70.0 K |
-41.4 % |
2018 |
FibroGen Inc
|
Independent Director |
265.5 K |
-1.7 % |
2018 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
|
Independent Director |
140 K |
33.3 % |
2018 |
Clearside Biomedical Inc
|
Independent Director |
119.4 K |
- |
2017 |
FibroGen Inc
|
Independent Director |
270.2 K |
43.7 % |
2017 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
|
Independent Director |
105 K |
- |
2016 |
FibroGen Inc
|
Independent Director |
188.0 K |
-34.1 % |
2016 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2015 |
FibroGen Inc
|
Independent Director |
285.4 K |
- |